Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
Accenture
Cantor Fitzgerald
Julphar
Deloitte

Generated: September 17, 2019

DrugPatentWatch Database Preview

Patent: 9,034,374

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,034,374
Title:Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine
Abstract: Novel acoustically sensitive drug carrying particles comprising non-lamellar forming lipids are disclosed, as well as uses and methods thereof. The drug carrying particles accumulate in the diseased target tissue and efficiently release their pay-load upon exposure to acoustic energy.
Inventor(s): Lauten; Cecilia Leal (Oslo, NO), Rognvaldsson; Karen Sibylla (Olso, NO), Fossheim; Sigrid L. (Oslo, NO), Nilssen; Esben A. (Oslo, NO), Evjen; Tove J. (Oslo, NO)
Assignee: IC TARGETS AS (Oslo, NO)
Application Number:13/376,690
Patent Claims:see list of patent claims

Details for Patent 9,034,374

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20 ➤ Sign Up IC TARGETS AS (Oslo, NO) 2029-06-08 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20 ➤ Sign Up IC TARGETS AS (Oslo, NO) 2029-06-08 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20 ➤ Sign Up IC TARGETS AS (Oslo, NO) 2029-06-08 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20 ➤ Sign Up IC TARGETS AS (Oslo, NO) 2029-06-08 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Sign Up IC TARGETS AS (Oslo, NO) 2029-06-08 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up IC TARGETS AS (Oslo, NO) 2029-06-08 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Citi
Boehringer Ingelheim
AstraZeneca
Fuji
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.